Smallpox therapy tecovirimat not efficacious in treating clade II mpox
1. In this phase 3, randomized, placebo-controlled trial, an antiviral medication approved for treating smallpox (tecovirimat) did not accelerate clinical ...
Tag: mpox
Extended incubation period identified in novel mpox strain
1. This surveillance study suggests that the incubation period of mpox virus (MPXV) clade Ib may be slightly longer than ...
Mpox cases in Africa continued to increase following WHO emergency declarations
1. The number of mpox cases in Africa increased leading up to the first mpox declaration of a Public Health ...
Adults with mpox have relatively low JYNNEOS vaccination rates
1. In this case-control study, adults with mpox were less likely to have been partially or fully vaccinated with the ...
HIV status does not impact mpox treatment with tecovirimat
1. In this retrospective study, tecovirimat was effective for treating mpox regardless of human immunodeficiency virus (HIV) status. 2. The ...
College campus mpox outbreaks can be controlled with timely detection and isolation
1. This stochastic dynamic model demonstrated that mpox outbreaks in the United States can be controlled on college campuses with ...
Characteristics of mpox virus infections across 16 countries
1. Patients with mpox infections presented with a variety of dermatologic and systemic symptoms. 2. Mpox virus infections were previously ...
